Our international focus is one of the reasons why the Cumming Global Centre for Pandemic Therapeutics is the first of its kind.
We take a partnership approach to attract global research expertise from diverse disciplines, driving long-term impact. We currently collaborate with 30+ institutions in 10 countries worldwide.
-
Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program
The AUD$54 million Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program funds groundbreaking research into early immunity to develop novel targets for therapeutics for pathogens of pandemic potential.